Published in Arch Biochem Biophys on October 12, 2008
Synthesis and antioxidant properties of an unnatural plasmalogen analogue bearing a trans O-vinyl ether linkage. Org Lett (2009) 0.90
The role of oxysterols in control of endothelial stiffness. J Lipid Res (2012) 0.87
Importance of the sphingosine base double-bond geometry for the structural and thermodynamic properties of sphingomyelin bilayers. Biophys J (2010) 0.79
A rapid method of total lipid extraction and purification. Can J Biochem Physiol (1959) 173.74
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab (2007) 6.83
Lipid rafts: bringing order to chaos. J Lipid Res (2003) 4.20
Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol (2000) 2.16
Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis. Am J Epidemiol (2006) 1.73
Interaction of cholesterol with sphingomyelin in monolayers and vesicles. Biochemistry (1994) 1.66
Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity. J Lipid Res (1982) 1.48
Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells. J Biol Chem (2007) 1.38
Membrane properties of D-erythro-N-acyl sphingomyelins and their corresponding dihydro species. Biophys J (2001) 1.33
Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction. J Biol Chem (1993) 1.12
Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J Biol Chem (1996) 1.12
Substrate specificity of rat brain ceramidase. J Lipid Res (2002) 1.08
The 4,5-double bond of ceramide regulates its dipole potential, elastic properties, and packing behavior. Biophys J (2004) 1.06
Role of group IIa and group V secretory phospholipases A(2) in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin. Biochemistry (2002) 1.03
The protective role of plasmalogens in iron-induced lipid peroxidation. Free Radic Biol Med (1999) 0.99
Conformational characterization of ceramides by nuclear magnetic resonance spectroscopy. Biophys J (2002) 0.98
Hydrogen bond formation as basis for radical scavenging activity: a structure-activity study of C-methylated dihydrochalcones from Myrica gale and structurally related acetophenones. Free Radic Biol Med (1997) 0.98
A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin. Arch Biochem Biophys (2001) 0.97
The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins. J Biol Chem (1996) 0.97
Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids. J Lipid Res (2006) 0.96
Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry (2005) 0.94
Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI. Biochem J (1997) 0.92
Role of sphingolipids in the biogenesis of membrane domains. Biochim Biophys Acta (2001) 0.92
Novel physiological function of sphingomyelin in plasma. Inhibition of lipid peroxidation in low density lipoproteins. J Biol Chem (1999) 0.92
Tamoxifen and related compounds decrease membrane fluidity in liposomes. Mechanism for the antioxidant action of tamoxifen and relevance to its anticancer and cardioprotective actions? FEBS Lett (1993) 0.91
Trans unsaturated fatty acids are less oxidizable than cis unsaturated fatty acids and protect endogenous lipids from oxidation in lipoproteins and lipid bilayers. Biochemistry (2003) 0.91
Methanolysis of sphingomyelin. Toward an epimerization-free methodology for the preparation of D-erythro-sphingosylphosphocholine. J Lipid Res (2000) 0.89
Role of sphingomyelin and ceramide in the regulation of the activity and fatty acid specificity of group V secretory phospholipase A2. Arch Biochem Biophys (2006) 0.87
Inhibitory effect of ethanolamine plasmalogen on iron- and copper-dependent lipid peroxidation. Free Radic Biol Med (1995) 0.86
First asymmetric synthesis of 6-hydroxy-4-sphingenine-containing ceramides. Use of chiral propargylic alcohols to prepare a lipid found in human skin. J Org Chem (2003) 0.86
Effect of sphingomyelin versus dipalmitoylphosphatidylcholine on the extent of lipid oxidation. Chem Phys Lipids (2003) 0.85
Glycated phosphatidylethanolamine promotes macrophage uptake of low density lipoprotein and accumulation of cholesteryl esters and triacylglycerols. J Biol Chem (1999) 0.82
Sphingomyelin: a natural modulator of membrane homeostasis and inflammation. Med Hypotheses (2001) 0.82
Side chain hydroxylation of cholesterol, campesterol and beta-sitosterol in rat liver mitochondria. J Lipid Res (1976) 0.79
Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids. Biochem J (1999) 0.78
Protection of membrane cholesterol by sphingomyelin against free radical-mediated oxidation. Free Radic Biol Med (2006) 0.78
The antioxidant action of synthetic oestrogens involves decreased membrane fluidity: relevance to their potential use as anticancer and cardioprotective agents compared to tamoxifen? Free Radic Res (1994) 0.78
Evaluation of a trans configuration for the apoptosis-inducing activity of ceramide. J Lipid Mediat Cell Signal (1997) 0.77
Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol Biol Cell (2003) 2.05
Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat Immunol (2011) 1.94
Lysophosphatidic acid induces neointima formation through PPARgamma activation. J Exp Med (2004) 1.86
Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. J Biol Chem (2007) 1.74
FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells. Cell Signal (2010) 1.73
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest (2013) 1.72
BODIPY-cholesterol: a new tool to visualize sterol trafficking in living cells and organisms. Traffic (2008) 1.67
Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase. J Biol Chem (2002) 1.63
Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis. J Biol Chem (2006) 1.61
Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest (2013) 1.57
FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells. J Biol Chem (2009) 1.46
A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol. J Lipid Res (2011) 1.45
First synthesis of free cholesterol-BODIPY conjugates. J Org Chem (2006) 1.45
The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. J Pharmacol Exp Ther (2007) 1.40
FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells. J Biol Chem (2011) 1.37
Correlated fluorescence-atomic force microscopy of membrane domains: structure of fluorescence probes determines lipid localization. Biophys J (2005) 1.33
Ceramide synthesis is modulated by the sphingosine analog FTY720 via a mixture of uncompetitive and noncompetitive inhibition in an Acyl-CoA chain length-dependent manner. J Biol Chem (2009) 1.32
Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules. Cancer Res (2011) 1.28
Novel ceramide analogs as potential chemotherapeutic agents in breast cancer. J Pharmacol Exp Ther (2004) 1.28
Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma. J Biol Chem (2005) 1.27
Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate. J Cell Biochem (2010) 1.24
(R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells. Cell Signal (2011) 1.22
Docosahexaenoic acid enhances segregation of lipids between : 2H-NMR study. Biophys J (2008) 1.20
Chiral vinylphosphonate and phosphonate analogues of the immunosuppressive agent FTY720. J Org Chem (2009) 1.19
Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin. J Virol (2002) 1.19
Raftlike mixtures of sphingomyelin and cholesterol investigated by solid-state 2H NMR spectroscopy. J Am Chem Soc (2008) 1.16
Inhibition of caveolar uptake, SV40 infection, and beta1-integrin signaling by a nonnatural glycosphingolipid stereoisomer. J Cell Biol (2007) 1.16
The sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent manner. Cell Signal (2011) 1.15
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood (2013) 1.14
Dual inhibition of mycobacterial fatty acid biosynthesis and degradation by 2-alkynoic acids. Chem Biol (2006) 1.13
Sterol effects and sites of sterol accumulation in Caenorhabditis elegans: developmental requirement for 4alpha-methyl sterols. J Lipid Res (2003) 1.12
Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells. Chembiochem (2006) 1.11
Use of Bodipy-labeled sphingolipid and cholesterol analogs to examine membrane microdomains in cells. Histochem Cell Biol (2008) 1.10
Effect of ceramide N-acyl chain and polar headgroup structure on the properties of ordered lipid domains (lipid rafts). Biochim Biophys Acta (2007) 1.08
Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. J Clin Invest (2014) 1.07
Structure and lipid interaction of N-palmitoylsphingomyelin in bilayer membranes as revealed by 2H-NMR spectroscopy. Biophys J (2005) 1.07
(S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity. Cell Signal (2010) 1.07
The 4,5-double bond of ceramide regulates its dipole potential, elastic properties, and packing behavior. Biophys J (2004) 1.06
Sphingolipid and cholesterol dependence of alphavirus membrane fusion. Lack of correlation with lipid raft formation in target liposomes. J Biol Chem (2002) 1.04
Role of ORPs in sterol transport from plasma membrane to ER and lipid droplets in mammalian cells. Traffic (2010) 1.03
Caveolar endocytosis and microdomain association of a glycosphingolipid analog is dependent on its sphingosine stereochemistry. J Biol Chem (2006) 1.03
Identification and characterization by electrospray mass spectrometry of endogenous Drosophila sphingadienes. J Lipid Res (2007) 1.02
Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. Am J Respir Cell Mol Biol (2013) 1.02
Retracted Visualization of lipid metabolism in the zebrafish intestine reveals a relationship between NPC1L1-mediated cholesterol uptake and dietary fatty acid. Chem Biol (2012) 1.00
Amot recognizes a juxtanuclear endocytic recycling compartment via a novel lipid binding domain. J Biol Chem (2010) 1.00
The hedgehog receptor patched is involved in cholesterol transport. PLoS One (2011) 1.00
NKT TCR recognition of CD1d-α-C-galactosylceramide. J Immunol (2011) 0.99
Role of sphingolipids in murine radiation-induced lung injury: protection by sphingosine 1-phosphate analogs. FASEB J (2011) 0.98
Fusion of alphaviruses with liposomes is a non-leaky process. FEBS Lett (2002) 0.98
Characterization of sphingosine-1-phosphate lyase activity by electrospray ionization-liquid chromatography/tandem mass spectrometry quantitation of (2E)-hexadecenal. Anal Biochem (2010) 0.97
Natural sphingadienes inhibit Akt-dependent signaling and prevent intestinal tumorigenesis. Cancer Res (2009) 0.96
Synthesis of immunostimulatory alpha-C-galactosylceramide glycolipids via Sonogashira coupling, asymmetric epoxidation, and trichloroacetimidate-mediated epoxide opening. Org Lett (2010) 0.95
Sphingosine 1-phosphate lyase enzyme assay using a BODIPY-labeled substrate. Biochem Biophys Res Commun (2009) 0.95
Interactions of very long-chain saturated fatty acids with serum albumin. J Lipid Res (2002) 0.95
Role of ceramide in membrane protein organization investigated by combined AFM and FCS. Biochim Biophys Acta (2008) 0.94
Chemopreventive sphingadienes downregulate Wnt signaling via a PP2A/Akt/GSK3β pathway in colon cancer. Carcinogenesis (2012) 0.93
Membrane fluidity and lipid order in ternary giant unilamellar vesicles using a new bodipy-cholesterol derivative. Biophys J (2009) 0.93
Synthesis of selective inhibitors of sphingosine kinase 1. Chem Commun (Camb) (2013) 0.93
Sphingosine interaction with acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) regulates PP2A activity and cyclooxygenase (COX)-2 expression in human endothelial cells. J Biol Chem (2010) 0.92
Intrinsic cytotoxicity and chemomodulatory actions of novel phenethylisothiocyanate sphingoid base derivatives in HL-60 human promyelocytic leukemia cells. J Pharmacol Exp Ther (2004) 0.92
LDL cholesterol recycles to the plasma membrane via a Rab8a-Myosin5b-actin-dependent membrane transport route. Dev Cell (2013) 0.91
Synthesis and spectral properties of cholesterol- and FTY720-containing boron dipyrromethene dyes. J Org Chem (2007) 0.91
The 3-hydroxy group and 4,5-trans double bond of sphingomyelin are essential for modulation of galactosylceramide transmembrane asymmetry. Biophys J (2005) 0.90
Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b. Int J Biochem Cell Biol (2012) 0.90
Antiviral activity of human lactoferrin: inhibition of alphavirus interaction with heparan sulfate. Virology (2005) 0.90
Synthesis of new trans double-bond sphingolipid analogues: Delta(4,6) and Delta(6) ceramides. J Org Chem (2002) 0.90
Synthesis and antioxidant properties of an unnatural plasmalogen analogue bearing a trans O-vinyl ether linkage. Org Lett (2009) 0.90
Stereochemical properties of lysophosphatidic acid receptor activation and metabolism. Biochim Biophys Acta (2002) 0.90
An efficient preparation of isosteric phosphonate analogues of sphingolipids by opening of oxirane and cyclic sulfamidate intermediates with alpha-lithiated alkylphosphonic esters. J Org Chem (2004) 0.90
Bax and Bcl-xL exert their regulation on different sites of the ceramide channel. Biochem J (2012) 0.89
Plasma gelsolin modulates cellular response to sphingosine 1-phosphate. Am J Physiol Cell Physiol (2010) 0.88
Quantitative assessment of sterol traffic in living cells by dual labeling with dehydroergosterol and BODIPY-cholesterol. Chem Phys Lipids (2011) 0.88
Behavior of a photoactivatable analog of cholesterol, 6-photocholesterol, in model membranes. FEBS Lett (2002) 0.88
Total synthesis of two photoactivatable analogues of the growth-factor-like mediator sphingosine 1-phosphate: differential interaction with protein targets. J Org Chem (2003) 0.88
FTY720 stimulates 27-hydroxycholesterol production and confers atheroprotective effects in human primary macrophages. Circ Res (2010) 0.87
The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells. Cell Signal (2013) 0.87
1-O-Hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol (Gln) induces cell death with more autophagosomes which is autophagy-independent. Autophagy (2009) 0.87
Membrane orientation and lateral diffusion of BODIPY-cholesterol as a function of probe structure. Biophys J (2013) 0.86
Interaction of the Vibrio cholerae cytolysin (VCC) with cholesterol, some cholesterol esters, and cholesterol derivatives: a TEM study. J Struct Biol (2002) 0.86
Tracking peptide-membrane interactions: insights from in situ coupled confocal-atomic force microscopy imaging of NAP-22 peptide insertion and assembly. J Struct Biol (2006) 0.86
Ceramide channels: influence of molecular structure on channel formation in membranes. Biochim Biophys Acta (2012) 0.86
Sphingosine-1-phosphate and the immunosuppressant, FTY720-phosphate, regulate detrusor muscle tone. FASEB J (2007) 0.86
Caged ceramide 1-phosphate analogues: synthesis and properties. J Org Chem (2009) 0.86
NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation. J Cell Sci (2013) 0.86
First asymmetric synthesis of 6-hydroxy-4-sphingenine-containing ceramides. Use of chiral propargylic alcohols to prepare a lipid found in human skin. J Org Chem (2003) 0.86
The sphingosine kinase inhibitor 2-(p-hyroxyanilino)-4-(p-chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress-dependent mechanism. Br J Pharmacol (2013) 0.86
Interaction of mammalian seminal plasma protein PDC-109 with cholesterol: implications for a putative CRAC domain. Biochemistry (2010) 0.86
Combined light and electron microscopy using diaminobenzidine photooxidation to monitor trafficking of lipids derived from lipoprotein particles. Curr Pharm Biotechnol (2012) 0.85
Cholesterol's aliphatic side chain modulates membrane properties. Angew Chem Int Ed Engl (2013) 0.85
Synthesis and growth inhibitory activity of chiral 5-hydroxy-2-N-acyl-(3E)-sphingenines: ceramides with an unusual sphingoid backbone. J Org Chem (2003) 0.84
The sphingolipid degradation product trans-2-hexadecenal forms adducts with DNA. Biochem Biophys Res Commun (2012) 0.84
Organization of fluorescent cholesterol analogs in lipid bilayers - lessons from cyclodextrin extraction. Biochim Biophys Acta (2013) 0.84
Sphingomyelin modulates the transbilayer distribution of galactosylceramide in phospholipid membranes. J Biol Chem (2002) 0.84
Total synthesis of α-1C-galactosylceramide, an immunostimulatory C-glycosphingolipid, and confirmation of the stereochemistry in the first-generation synthesis. J Org Chem (2011) 0.83
FTY720 (Gilenya) phosphate selectivity of sphingosine 1-phosphate receptor subtype 1 (S1P1) G protein-coupled receptor requires motifs in intracellular loop 1 and transmembrane domain 2. J Biol Chem (2011) 0.83
Liposomes as target membranes in the study of virus receptor interaction and membrane fusion. Methods Enzymol (2003) 0.83
Synthesis of C-glycoside analogues of α-galactosylceramide via linear allylic C-H oxidation and allyl cyanate to isocyanate rearrangement. Org Lett (2012) 0.83